You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

subgenomic%20RNA

Showing 1 - 25 of 1,405
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SARS-CoV-2 Infection, COVID-19 Trial in Derby (Remdesivir)

Not yet recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • Derby, United Kingdom
    University of Derby
Jun 21, 2023

Index Individuals in SARS-CoV-2 Prevention Research Studies

Completed
  • SARS-CoV-2 Infection
  • +3 more
    • Seattle, Washington
      University of Washington International Clinical Research Center
    Dec 6, 2021

    COVID-19: Infectious Potential of SARS-CoV-2 Intestinal Shedding

    Active, not recruiting
    • SARS-CoV-2 Infection
    • +2 more
      • Vienna, Austria(AUT), Austria
      • +3 more
      May 4, 2022

      Respiratory Tract and Lung Parenchyma

      Recruiting
      • Covid19
      • Lung biopsy
      • Leuven, Belgium
        UZ Leuven
      Mar 8, 2021

      Bioaerosol Sampling Device (BSD) Clinical Study

      Recruiting
      • COVID-19
        • S. Gate, California
        • +5 more
        Sep 14, 2023

        Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, Autosomal Dominant Polycystic Kidney Trial in

        Not yet recruiting
        • Atypical Hemolytic Uremic Syndrome
        • +3 more
        • Skin biopsy
        • Ranica, BG, Italy
          Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
        Aug 9, 2023

        Metastatic Renal Cell Carcinoma Trial in Shanghai (sunitinib or pazopanib, PD-1 inhibitor combined with axitinib)

        Recruiting
        • Metastatic Renal Cell Carcinoma
        • sunitinib or pazopanib
        • PD-1 inhibitor combined with axitinib
        • Shanghai, Shanghai, China
          Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
        Apr 16, 2023

        Development of Targeted RNA-Seq for Amyotrophic Lateral

        Not yet recruiting
        • Amyotrophic Lateral Sclerosis
        • RNA sequencing
        • Bordeaux, France
        • +6 more
        Oct 9, 2023

        Pulmonary Osteosarcoma Trial (RNA-LP vaccine)

        Not yet recruiting
        • Pulmonary Osteosarcoma
        • RNA-LP vaccine
        • (no location specified)
        Jan 25, 2023

        Influenza, Human Trial in Brisbane (ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine

        Not yet recruiting
        • Influenza, Human
        • ARCT-2138
        • +2 more
        • Brisbane, Queensland, Australia
          Nucleus Network Brisbane Clinic
        Nov 8, 2023

        Therapeutic Plasma Exchange on RNA Biomarker Expression Levels

        Recruiting
        • Alzheimer Disease
          • Brentwood, Tennessee
            The MaxWell Clinic
          Oct 11, 2023

          MIRACLE of LIFE Study

          Active, not recruiting
          • Preterm Labor
          • +9 more
          • Mirvie Predictive Test for Adverse Pregnancy Outcomes
          • San Diego, California
          • +9 more
          Oct 3, 2023

          Health-related Quality of Life in HIV-1 Infected Adults

          Active, not recruiting
          • HIV-1-infection
          • Montréal, Canada
          • +5 more
          Sep 22, 2022

          SARS-CoV2 Infection Trial in Newark (Testing for SARS CoV2 RNA)

          Completed
          • SARS-CoV2 Infection
          • Testing for SARS CoV2 RNA
          • Newark, New Jersey
            Rutgers School of Dental Medicine
          Nov 5, 2022

          Chemoresistance Mechanisms in Pancreatic Cancer

          Not yet recruiting
          • Patients With Non-metastatic Pancreatic Cancer
          • Evaluation of Tumor Resectability Shall be Made in Consensus at Multidisciplinary Meetings, According to NCCN Guideline Version 1.2022 Pancreatic Adenocarcinoma
          • ctDNA detection
          • Shanghai, Shanghai, China
            Zhongshan Hospital
          Apr 27, 2023

          Esophagus Cancer Trial in Xiamen (Tislelizumab, Paclitaxel-albumin, Carboplatin)

          Recruiting
          • Esophagus Cancer
          • Xiamen, Fujian, China
            ShanghaiZhongshan
          Apr 8, 2023

          Malaria Trial (BNT165e, Placebo)

          Not yet recruiting
          • Malaria
          • BNT165e
          • Placebo
          • (no location specified)
          Sep 29, 2023

          Congenital Hearing Loss Trial in Shanghai (HG205)

          Not yet recruiting
          • Congenital Hearing Loss
          • HG205
          • Shanghai, China
            Eye & ENT Hospital of Fudan University
          Aug 29, 2023

          Chronic Rhinosinusitis With Nasal Polyps Trial in Vancouver (Mepolizumab)

          Not yet recruiting
          • Chronic Rhinosinusitis With Nasal Polyps
          • Vancouver, British Columbia, Canada
            St. Paul's Sinus Centre
          Oct 24, 2023

          Hepatitis Delta Virus Trial in Worldwide (Peginterferon Lambda-1a)

          Recruiting
          • Hepatitis Delta Virus
          • Peginterferon Lambda-1a
          • Los Angeles, California
          • +61 more
          Jan 30, 2023

          Advanced Esophageal Squamous Cell Carcinoma Trial in Beijing, Xiamen, Xinxiang (Afatinib, Irinotecan)

          Recruiting
          • Advanced Esophageal Squamous Cell Carcinoma
          • Beijing, China
          • +2 more
          Apr 6, 2023

          COVID-19, Influenza Trial in United States (Lucira COVID-19 & Flu Test)

          Completed
          • COVID-19
          • Influenza
          • Lucira COVID-19 & Flu Test
          • Cullman, Alabama
          • +6 more
          Nov 16, 2023

          Hepatitis C, Chronic Trial in Albuquerque (HCV RNA screening)

          Terminated
          • Hepatitis C, Chronic
          • HCV RNA screening
          • Albuquerque, New Mexico
          • +1 more
          Oct 26, 2022

          Infertility in Men (MODIFY)

          Recruiting
          • Male Infertility
            • Singapore, Singapore
              Human Development Research Centre (HDRC)
            Nov 21, 2023

            Healthy Adult Volunteers Trial in Taipei City (ChAdOx1-nCov-19 (Astra-Zeneca), SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine)

            Completed
            • Healthy Adult Volunteers
            • ChAdOx1-nCov-19 (Astra-Zeneca)
            • SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine
            • Taipei City, X, Taiwan
              National Taiwan University Hospital
            Oct 16, 2022